Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Targeting deubiquitinase USP28 for cancer therapy
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Targeting deubiquitinase USP28 for cancer therapy
Creator
Zhang, Li
Jia, Lijun
Yu, Xiaoli
Zhang, Zhen
Feng, Yan
Chen, Xingxing
Fu, Shen
Guo, Xiaomao
Liu, Zhiyi
Luo, Jurui
Ma, Jinli
Mei, Xin
Shao, Zhimin
Wang, Xiaofang
Wei, Dongping
Yang, Zhaozhi
Zhou, Zhirui
source
Medline; PMC
abstract
As one of the most important post-translational modifications, ubiquitination plays versatile roles in cancer-related pathways, and is involved in protein metabolism, cell-cycle progression, apoptosis, and transcription. Counteracting the activities of the E3 ligases, the deubiquitylating enzymes have been suggested as another important mechanism to modulate the ubiquitination process, and are implicated in cancer as well. In this article, we review the emerging roles of USP28 in cancer pathways as revealed by recent studies. We discuss the major mechanisms by which USP28 is involved in the cancer-related pathways, whereby USP28 regulates physiological homeostasis of ubiquitination process, DNA-damage response, and cell cycle during genotoxic stress. We further review the studies where USP28 was targeted for treating multiples cancers including non-small cell lung cancer, breast cancer, intestinal cancers, gliomas, and bladder cancer. As a result, the clinical significance of targeting USP28 for cancer therapy merits further exploration and demonstration.
has issue date
2018-02-07
(
xsd:dateTime
)
bibo:doi
10.1038/s41419-017-0208-z
bibo:pmid
29415985
has license
cc-by
sha1sum (hex)
ecf2675fbb7883ca4a8f98c34eadb55c6b857aaa
schema:url
https://doi.org/10.1038/s41419-017-0208-z
resource representing a document's title
Targeting deubiquitinase USP28 for cancer therapy
has PubMed Central identifier
PMC5833459
has PubMed identifier
29415985
schema:publication
Cell Death Dis
resource representing a document's body
covid:ecf2675fbb7883ca4a8f98c34eadb55c6b857aaa#body_text
is
schema:about
of
named entity 'TARGETING'
named entity 'cell cycle'
named entity 'enzymes'
named entity 'cancer therapy'
named entity 'RECENT'
named entity 'WHERE'
named entity 'DAMAGE RESPONSE'
named entity 'MULTIPLES'
named entity 'INTESTINAL CANCERS'
named entity 'IMPORTANT'
named entity 'INCLUDING'
named entity 'TREATING'
named entity 'PLAYS'
named entity 'MAJOR'
named entity 'NON-SMALL CELL LUNG CANCER'
named entity 'REVEALED'
named entity 'ACTIVITIES'
named entity 'LIGASES'
named entity 'APOPTOSIS'
named entity 'PROGRESSION'
named entity 'MODULATE'
named entity 'RESULT'
named entity 'UBIQUITINATION'
named entity 'DNA-DAMAGE'
named entity 'INVOLVED'
named entity 'REVIEW'
named entity 'CLINICAL SIGNIFICANCE'
named entity 'GLIOMAS'
named entity 'MECHANISM'
named entity 'TRANSCRIPTION'
named entity 'CANCER'
named entity 'TARGETING'
named entity 'ONE OF'
named entity 'PROTEIN METABOLISM'
named entity 'STUDIES'
named entity 'MECHANISMS'
named entity 'GENOTOXIC STRESS'
named entity 'DEMONSTRATION'
named entity 'EXPLORATION'
named entity 'DEUBIQUITINASE'
named entity 'CANCER THERAPY'
named entity 'BREAST CANCER'
named entity 'PATHWAYS'
named entity 'RELATED'
named entity 'PHYSIOLOGICAL HOMEOSTASIS'
named entity 'ARTICLE'
named entity 'BLADDER CANCER'
named entity 'PROCESS'
named entity 'CELL CYCLE'
named entity 'ENZYMES'
named entity 'CELL-CYCLE'
named entity 'USP28'
named entity 'ROLES'
named entity 'USP28'
named entity 'POST-TRANSLATIONAL MODIFICATIONS'
named entity 'DISCUSS'
named entity 'HAVE'
named entity 'CANCERS'
named entity 'CANCER THERAPY'
named entity 'TARGETED'
named entity '2C CELL'
covid:arg/ecf2675fbb7883ca4a8f98c34eadb55c6b857aaa
named entity 'process'
named entity 'apoptosis'
named entity 'transcription'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 9
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software